Prevalence and patterns of antiretroviral resistance in HIV-infected Latin American asylum seekers
- PMID: 40759719
- PMCID: PMC12322263
- DOI: 10.1038/s41598-025-13673-1
Prevalence and patterns of antiretroviral resistance in HIV-infected Latin American asylum seekers
Abstract
The recent increase in Latin American asylum seekers in Spain has been accompanied by a rise in HIV diagnoses. However, their clinical profile, particularly regarding antiretroviral resistance, is poorly characterized. We aimed to assess the prevalence of resistance-associated mutations and their impact on treatment management in this vulnerable population. We conducted a prospective cohort study (2022-2023) with six-month follow-up, enrolling Latin American asylum seekers living with HIV, attending their first HIV consultation in Spain. Individuals with a viral load > 1,000 copies/mL, regardless of prior ART exposure, underwent genotypic resistance testing. Mutations were identified using the WHO Surveillance Drug Resistance Mutations (SDRM) list, and resistance was interpreted via the Stanford HIV Drug Resistance Database algorithm. Of 653 participants, 153 met inclusion criteria, and 141 (21.6%) had valid resistance results. Overall, 22.7% harbored SDRMs to NNRTIs, NRTIs, or PIs (15.0% ART-naïve vs. 32.8% ART-experienced). NNRTI mutations were most frequent (21.3%), particularly in ART-experienced individuals (31.1%). NRTI mutations were present in 7.1% overall (13.1% ART-experienced). The most common mutations were K103N/S (19.1%), P225H (5.0%), and M184V (4.3%). Among ART-experienced individuals, resistance to efavirenz, nevirapine, and rilpivirine was 31.1%, 32.7%, and 19.7%, respectively; 11.4% showed lamivudine resistance. Notably, 82.3% of ART-experienced participants reported barriers to healthcare access, with a 90% rate of treatment discontinuation. In this cohort of Latin American asylum seekers, resistance to NNRTIs was alarmingly high, especially among those with prior ART exposure and interrupted treatment. These findings underscore the need for optimized treatment strategies and improved healthcare access for migrant populations with HIV.
Keywords: Asylum seekers; HIV; Latin american; Migrants; Mutations; Resistance.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethical approval and consent to participate: This study complied with the Declaration of Helsinki and adhered to the STROBE guidelines for reporting observational studies (see Supplementary Material). The study protocol was approved by the Infanta Leonor Hospital Research Ethics Board in 2022 and was registered at ClinicalTrials.gov (NCT05998499). Informed consent was obtained from all participants prior to inclusion.
Figures





Similar articles
-
Prevalence of Doravirine Resistance Mutations in a Large-Scale HIV-1 Transmitted Drug Resistance Survey in Buenos Aires, Argentina.Viruses. 2025 May 20;17(5):731. doi: 10.3390/v17050731. Viruses. 2025. PMID: 40431742 Free PMC article.
-
Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in Cameroon.J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241306484. doi: 10.1177/23259582241306484. J Int Assoc Provid AIDS Care. 2024. PMID: 39711049 Free PMC article.
-
Prevalence of acquired resistance to antiretrovirals in children and adolescents living with HIV under clinical follow-up at the Roosevelt Hospital in Guatemala.J Infect Public Health. 2025 Sep;18(9):102827. doi: 10.1016/j.jiph.2025.102827. Epub 2025 May 13. J Infect Public Health. 2025. PMID: 40479964
-
Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.Cochrane Database Syst Rev. 2016 Dec 10;12(12):CD004246. doi: 10.1002/14651858.CD004246.pub4. Cochrane Database Syst Rev. 2016. PMID: 27943261 Free PMC article.
-
Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD008270. doi: 10.1002/14651858.CD008270.pub2. Cochrane Database Syst Rev. 2013. PMID: 23740608 Free PMC article.
References
-
- Hoja informativa —. Últimas estadísticas sobre el estado de la epidemia de sida [Internet]. [citado 16 de septiembre de 2024]. Disponible en: https://www.unaids.org/es/resources/fact-sheet
-
- By-Nc-Sa, C. Unidad de vigilancia de VIH, ITS y hepatitis. Vigilancia Epidemiológica del VIH y sida en España. : Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida. Centro Nacional de Epidemiología. Instituto de Salud Carlos III/ División de control de VIH, ITS, Hepatitis virales y tuberculosis. Ministerio de Sanidad. Madrid; noviembre 2024. (2023).
-
- European Commission. Eurostat. Migration and asylum in Europe [Internet]. LU: Publications Office; 2023 [citado 18 de septiembre de 2024]. (Migration and asylum in Europe …Disponible en: https://data.europa.eu/doi/10.2785/353399.
-
- INE [Internet]. INEbase / Demografía y población /Fenómenos demográficos /Estadística de Migraciones y Cambios de Residencia / Últimos datos (&cid=1254736177098&menu=ultiDatos&idp=1254735573002, ).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous